In the GMALL 05/93 and 06/99 trials, among 126 adult T-ALL patients, NOTCH1 and FBXW7 mutations were associated with favorable outcomes but only with low expression of ERG and BAALC [66]. This evidence concerns the gene FBXW7 and acute lymphoblastic leukemia.